Cancer Research UK logo.
SearchDonate
  • Search

A study looking at treatment for high risk neuroblastoma (HR/NBL2/SIOPEN)

Overview

Cancer types:

Children's cancers, Children's neuroblastoma

Status:

Open

Phase:

Phase 3

Details

This study is looking at chemotherapy, radiotherapy and stem cell transplants for people with high risk neuroblastoma.

It is open to children and young people with a high risk that:

  • is newly diagnosed, and

  • you are about to start chemotherapy

Please note, we use the term ‘you’ in this summary, but of course if you are a parent of a child with cancer, we are referring to your child.

Recruitment start: 26 August 2021

Recruitment end: 31 December 2027

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Martin Elliot

Supported by

Cancer Research UK Clinical Trials Unit, Birmingham

International Society of Paediatric Oncology (SIOP)

Solving Kids Cancer (SKC)

Gustave Roussy

SIOPEN

Neuroblastoma UK

Last reviewed: 01 May 2025

CRUK internal database number: 18381

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.